Article thumbnail

A Novel Role of RASSF9 in Maintaining Epidermal Homeostasis

By Chiou-Mei Lee, Polung Yang, Lih-Chyang Chen, Chia-Chun Chen, Shinn-Chih Wu, Hsiao-Yun Cheng and Yu-Sun Chang

Abstract

The physiological role of RASSF9, a member of the Ras-association domain family (RASSF), is currently unclear. Here, we report a mouse line in which an Epstein-Barr virus Latent Membrane Protein 1 (LMP1) transgene insertion has created a 7.2-kb chromosomal deletion, which abolished RASSF9 gene expression. The RASSF9-null mice exhibited interesting phenotypes that resembled human ageing, including growth retardation, short lifespan, less subcutaneous adipose layer and alopecia. In the wild-type mice, RASSF9 is predominantly expressed in the epidermal keratinocytes of skin, as determined by quantitative reverse-transcription PCR, immunofluorescence and in situ hybridization. In contrast, RASSF9−/− mice presented a dramatic change in epithelial organization of skin with increased proliferation and aberrant differentiation as detected by bromodeoxyuridine incorporation assays and immunofluorescence analyses. Furthermore, characteristic functions of RASSF9−/− versus wild type (WT) mouse primary keratinocytes showed significant proliferation linked to a reduction of p21Cip1 expression under growth or early differentiation conditions. Additionally, in RASSF9−/− keratinocytes there was a drastic down-modulation of terminal differentiation markers, which could be rescued by infection with a recombinant adenovirus, Adv/HA-RASSF9. Our results indicate a novel and significant role of RASSF9 in epidermal homeostasis

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3061870
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1996). A
  2. (2005). A novel intronic cis element, ISE/ISS-3, regulates rat fibroblast growth factor receptor 2 splicing through activation of an upstream exon and repression of a downstream exon containing a noncanonical branch point sequence.
  3. (2009). A tale of terminal differentiation: IKKalpha, the master keratinocyte regulator.
  4. (2004). An intronic enhancer regulates splicing of the twintron of Drosophila melanogaster prospero pre-mRNA by two different spliceosomes.
  5. (2007). Calcium enhances mouse keratinocyte differentiation in vitro to differentially regulate expression of papillomavirus authentic and codon modified L1 genes.
  6. (2005). Calcium-induced human keratinocyte differentiation requires src- and fyn-mediated phosphatidylinositol 3-kinase-dependent activation of phospholipase C-gamma1.
  7. (2005). Characterization of the intronic splicing silencers flanking FGFR2 exon IIIb.
  8. (1992). Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population.
  9. (2005). Depletion of TDP 43 overrides the need for exonic and intronic splicing enhancers in the human apoA-II gene.
  10. (1995). Dutta A
  11. (2009). Effects of extracellular calcium on the growth-differentiation switch in immortalized keratinocyte HaCaT cells compared with normal human keratinocytes.
  12. (1990). Epidermal differentiation.
  13. (1988). Genetic applications of an inverse polymerase chain reaction.
  14. (2009). H-ras expression in immortalized keratinocytes produces an invasive epithelium in cultured skin equivalents.
  15. (2003). Hair cycle regulation of Hedgehog signal reception.
  16. (2001). Hyperproliferation and defects in epithelial polarity upon conditional ablation of alpha-catenin in skin.
  17. (1997). Identification of a promoter for the latent membrane protein 1 gene of Epstein-Barr virus that is specifically activated in human epithelial cells.
  18. (2002). Impaired hair follicle morphogenesis and cycling with abnormal epidermal differentiation in nackt mice, a cathepsin L-deficient mutation.
  19. (1998). Inhibitory function of p21Cip1/WAF1 in differentiation of primary mouse keratinocytes independent of cell cycle control.
  20. (1995). Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation.
  21. (2010). Keratinocyte differentiation induced by calcium, phorbol ester or interferon-gamma elicits distinct changes in the retinoid signalling pathways.
  22. (2002). Modulation of the Ras/ Raf/MEK/ERK pathway by Ca(2+), and calmodulin.
  23. (2002). Molecular mechanisms regulating hair follicle development.
  24. (1981). Mouse skin cells resistant to terminal differentiation associated with initiation of carcinogenesis.
  25. (2001). Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation.
  26. (1998). P-CIP1, a novel protein that interacts with the cytosolic domain of peptidylglycine alpha-amidating monooxygenase, is associated with endosomes.
  27. (1995). p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells.
  28. (2005). Ras-induced spreading and wound closure in human epidermal keratinocytes.
  29. (2000). Rasindependent activation of the Raf/MEK/ERK pathway upon calcium-induced differentiation of keratinocytes.
  30. (2008). RASSF7 is a member of a new family of RAS association domain-containing proteins and is required for completing mitosis.
  31. (2002). Regulation of phospholipase C activation by the number of H(2) receptors during Ca(2+)-induced differentiation of mouse keratinocytes.
  32. (1997). Sequence variations between two Epstein-Barr virus LMP 1 variants have no effect on the activation of NF-kappaB activity.
  33. (2004). Signaling specificity by Ras family GTPases is determined by the full spectrum of effectors they regulate.
  34. (1990). Skin hyperkeratosis and papilloma formation in transgenic mice expressing a ras oncogene from a suprabasal keratin promoter.
  35. (2003). Splicing of a myosin phosphatase targeting subunit 1 alternative exon is regulated by intronic cis-elements and a novel bipartite exonic enhancer/silencer element.
  36. (1996). The absence of p21Cip1/WAF1 alters keratinocyte growth and differentiation and promotes ras-tumor progression.
  37. (2005). The cornified envelope: a model of cell death in the skin.
  38. (1997). The epidermal keratinocyte as a model for the study of gene regulation and cell differentiation.
  39. (1988). The marmoset B-lymphoblastoid cell line (B95-8) produces and responds to B-cell growth and differentiation factors: role of shed
  40. (2009). The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias.
  41. (2010). The Nterminal RASSF family: a new group of Ras-association-domain-containing proteins, with emerging links to cancer formation.
  42. (2007). The Ras-association domain family (RASSF) members and their role in human tumourigenesis.
  43. (2009). The RASSF proteins in cancer; from epigenetic silencing to functional characterization.
  44. (1998). The two functional keratin 6 genes of mouse are differentially regulated and evolved independently from their human orthologs.
  45. (2000). Transgenic coexpression of v-Haras and transforming growth factor alpha increases epidermal hyperproliferation and tumorigenesis and predisposes to malignant conversion via endogenous cHa-ras activation.
  46. (1998). Up-regulation of p21WAF1 by phorbol ester and calcium in human keratinocytes through a protein kinase C-dependent pathway.